位置:首页 > 产品库 > Tegaserod maleate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Tegaserod maleate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Tegaserod maleate图片
CAS NO:189188-57-6

马来酸替加色罗
SDZ-HTF-919
HTF-919
Tegaserod maleate (SDZ-HTF-919) 是一种口服有效的 5-羟色胺受体 4 (HTR4;5-HT4R) 激动剂和5-HT2B受体拮抗剂。Tegaserod maleate 对人重组 5-HT2A、5-HT2B和 5-HT2C受体的 pKis 分别为 7.5、8.4 和 7.0。Tegaserod maleate 导致肿瘤细胞凋亡,减弱 PI3K/Akt/mTOR 信号传导并降低 S6 磷酸化。Tegaserod maleate 具有抗肿瘤活性,同时具有用于肠易激综合征 (IBS) 研究的潜力。
生物活性

Tegaserod maleate (SDZ-HTF-919) is an orally activeserotonin receptor 4(HTR4;5-HT4R) agonist and a5-HT2Breceptor antagonist. Tegaserod maleate has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2Band 5-HT2Creceptors, respectively. Tegaserod maleate causes tumor cellapoptosis, bluntsPI3K/Akt/mTORsignaling and decreases S6 phosphorylation. Tegaserod maleate has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research[1][2][3].

IC50& Target

5-HT4Receptor

 

5-HT2BReceptor

 

体外研究
(In Vitro)

马来酸替加色罗 (SDZ-HTF-919; 3-5 μM; 24-72 小时) 引起显着的时间和剂量依赖性细胞凋亡增加[1]
马来酸替加色罗 (3-5 μM; 8-18 小时) 降低 p-S6 ,p-p70 S6 (Thr421/Ser424)[1]
马来酸替加色罗 (0.1-3 μM; 24 小时) 有效抑制 5-HT 介导的大鼠离体胃底收缩 (pA2=8.3),与 5-HT2B受体拮抗剂活性一致[3]

Apoptosis Analysis[1]

Cell Line:A375, RPMI-7951 (RPMI), SH4, B16F10, MeWo and MEL-JUSO
Concentration:3, 5 μM
Incubation Time:24, 48, 72 h
Result:There was a significant time and dose-dependent increase in apoptosis in all cell lines.

Western Blot Analysis[1]

Cell Line:RPMI, SH4 and B16F10 cells
Concentration:3, 5 μM
Incubation Time:8 or 18 h
Result:Decreased phosphorylation of the kinase directly upstream of S6, p70 S6 at Thr421/Ser424.
体内研究
(In Vivo)

马来酸替加色罗 (SDZ-HTF-919; 5 mg/kg/天; 腹腔注射; 连续五天) 在体内延迟肿瘤生长、减少转移、增加存活率并抑制 p-S6[1]
马来酸替加色罗 (0.1-2.0 mg/kg; 胃负荷前 15 分钟腹腔注射) 显着加速 db/db 小鼠的胃葡萄糖排空率,在 0.1mg/kg 的情况下将 30 分钟时留在胃中的膳食部分减少 80%[2].

Animal Model:C57BL/6 J mice were subcutaneously injected with B16F10 cells[1]
Dosage:5 mg/kg
Administration:Administered intraperitoneally (i.p.) daily for five consecutive days
Result:Treatment significantly decreased tumor growth and resulted in only slight decreases in weight following treatment.
Animal Model:Female C57BLKS/J db/db mice[2]
Dosage:0.1, 0.5, 1.0, 2.0 mg/kg
Administration:IP; 15 min prior to gastric loading
Result:Produced a dramatic decrease in the fraction of the meal remaining in the stomach for doses as low as 0.1 mg/kg (0.1 mg/kg).
Accelerated gastric emptying, with a reduction of nearly 80% in the fraction remaining at 30 min (P< 0.0001) (0.1 mg/kg).
Induced a significant decrease in the gastric emptying rate as the amount of the meal remaining at 30 min was significantly greater (2.0 mg/kg).
Resulted in inhibition of tegaserod-induced increased gastric emptying (0.1 mg/kg).
Clinical Trial
分子量

417.46

性状

Solid

Formula

C20H27N5O5

CAS 号

189188-57-6

中文名称

马来酸替加色罗

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : ≥ 35 mg/mL(83.84 mM)

H2O : 1 mg/mL(2.40 mM;Need ultrasonic)

*"≥" means soluble, but saturation unknown.

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.3954 mL11.9772 mL23.9544 mL
5 mM0.4791 mL2.3954 mL4.7909 mL
10 mM0.2395 mL1.1977 mL2.3954 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40%PEG300   5%Tween-80   45% saline

    Solubility: ≥ 2.5 mg/mL (5.99 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.99 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH2O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90%corn oil

    Solubility: ≥ 2.5 mg/mL (5.99 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.99 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在本网站选购。
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024